It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The angiotensin-converting enzyme 2 (ACE2) is a viral receptor used by sarbecoviruses to infect cells. Fusion proteins comprising extracellular ACE2 domains and the Fc part of immunoglobulins exhibit high virus neutralization efficiency, but the structure and stability of these molecules are poorly understood. We show that although the hinge between the ACE2 and the IgG4-Fc is highly flexible, the conformational dynamics of the two ACE2 domains is restricted by their association. Interestingly, the conformational stability of the ACE2 moiety is much lower than that of the Fc part. We found that chemical compounds binding to ACE2, such as DX600 and MLN4760, can be used to strongly increase the thermal stability of the ACE2 by different mechanisms. Together, our findings reveal a general concept for stabilizing the labile receptor segments of therapeutic antiviral fusion proteins by chemical compounds.
The solution structure, stability, and dynamics of a broadly-acting antiviral ACE2-IgG-Fc fusion protein are determined. Small chemical compounds binding to ACE2 can be used to drastically increase the thermal stability of the ACE2 domain.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Technical University of Munich, Center for Functional Protein Assemblies (CPA) and School of Natural Sciences, Department of Bioscience, Garching, Germany (GRID:grid.6936.a) (ISNI:0000000123222966); Ghent University, Faculty of Pharmaceutical Sciences, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798)
2 Helmholtz Zentrum München, Institute of Structural Biology, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Technical University of Munich, Bavarian NMR Center, School of Natural Sciences, Department of Bioscience, Garching, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
3 Technical University of Munich, Center for Functional Protein Assemblies (CPA) and School of Natural Sciences, Department of Bioscience, Garching, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
4 Formycon AG, Martinsried/Planegg, Germany (GRID:grid.6936.a)
5 Brockmeyer Biopharma GmbH, Marzling, Germany (GRID:grid.6936.a)